Regeneron Pharmaceuticals target price raised by Wells Fargo to $925 from $750
REGN•Wells Fargo raised its target price for Regeneron Pharmaceuticals to $925 from $750.
Related News
CytomX Therapeutics presents at Guggenheim and Jefferies healthcare conferences
CTMX•
Xeris Biopharma appoints Menassie M. Taddese to board of directors
XERS•
Standard Nuclear partners with SHINE Technologies to develop fuel from recycled nuclear material
STDN•
Oil drops more than 4% on talks aimed at ending US-Iran war
USO•
Humacyte sets third-quarter financial results call
HUMA•